136 related articles for article (PubMed ID: 3243309)
1. Evaluation of a new leukocyte labeling procedure with 99mTc-HMPAO.
Kelbaek H; Linde J; Nielsen SL
Eur J Nucl Med; 1988; 14(12):621-3. PubMed ID: 3243309
[TBL] [Abstract][Full Text] [Related]
2. [99mTc-HMPAO labeling of leukocytes and thrombocytes. Characteristics and diagnostic consequences].
Becker W; Börner W
Rofo; 1988 Jan; 148(1):69-74. PubMed ID: 2829311
[TBL] [Abstract][Full Text] [Related]
3. Technetium-99m exametazime (99mTc-HMPAO)-labeled white blood cells: a high efficiency multidose procedure.
Ozker K; Collier BD; Hellman RS; Isitman AT; Uzum F; Steffel FG
Eur J Nucl Med; 1995 Feb; 22(2):182-3. PubMed ID: 7758507
[No Abstract] [Full Text] [Related]
4. In vitro comparison of HMPAO and gentisic acid for labelling leukocytes with 99mTc.
Ecclestone M; Proulx A; Ballinger JR; Gerson B; Reid RH; Gulenchyn KY
Eur J Nucl Med; 1990; 16(4-6):299-302. PubMed ID: 2161770
[TBL] [Abstract][Full Text] [Related]
5. New synthesis route of active substance d,l-HMPAO for preparation Technetium Tc99m Exametazime.
Pijarowska-Kruszyna J; Karczmarczyk U; Jaroń AW; Laszuk E; Radzik M; Garnuszek P; Mikołajczak R
Nucl Med Rev Cent East Eur; 2017; 20(2):88-94. PubMed ID: 28555448
[TBL] [Abstract][Full Text] [Related]
6. Leukocyte labeling with 99mTc-HMPAO. The role of the in vitro stability of HMPAO on the labeling efficacy and image quality.
Papós M; Láng J; Rajtár M; Csernay L
Nucl Med Biol; 1994 Aug; 21(6):893-5. PubMed ID: 9234340
[No Abstract] [Full Text] [Related]
7. An in vitro study to compare 99mTc-stannous colloids and 99mTc-HMPAO for labelling human leukocytes.
Capriotti G; D'Alessandria C; Garin E; Weber E; Devillers A; Lehmann K; Corsetti F; Lecloirec J; Meller J; Becker W; Moisan A; Signore A
Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):229-36. PubMed ID: 15499297
[TBL] [Abstract][Full Text] [Related]
8. Use of stabilized technetium-99m-exametazime for radiolabeling leukocytes.
Hung JC; Chowdhury S; Mullan BP
J Nucl Med; 1998 May; 39(5):912-7. PubMed ID: 9591600
[TBL] [Abstract][Full Text] [Related]
9. 99mTc labeling white blood cells with a simple technique: clinical application.
Gutfilen B; Pellini MP; de Roure e Neder J; de Amarante Júnior JL; Evangelista MG; Fernandes SR; Bernardo-Filho M
Ann Nucl Med; 1994 Feb; 8(1):85-9. PubMed ID: 8204402
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of 99Tcm-d,l-HMPAO and 99Tcm-d,l-CBPAO as leukocyte-labelling agents.
Tsai CS; Kao CH; Yeh SJ; Wang SJ
Nucl Med Commun; 1996 Jan; 17(1):76-9. PubMed ID: 8692477
[TBL] [Abstract][Full Text] [Related]
11. Validation of the leukocyte labeling procedure with a new kit for the preparation of technetium-99m exametazime injection.
Martinez T; Gallego Peinado M; Sanchez Catalicio J; Perez Angel F; Contreras Gutiérrez J
Nucl Med Commun; 2016 Apr; 37(4):432-4. PubMed ID: 26657217
[TBL] [Abstract][Full Text] [Related]
12. Clinical experience with 99mTc-hexamethylpropylene-amineoxime for labelling leucocytes and imaging inflammation.
Peters AM; Danpure HJ; Osman S; Hawker RJ; Henderson BL; Hodgson HJ; Kelly JD; Neirinckx RD; Lavender JP
Lancet; 1986 Oct; 2(8513):946-9. PubMed ID: 2877132
[TBL] [Abstract][Full Text] [Related]
13. A new 99mTc labelling method for leucocytes: in vitro and in vivo comparison with 99mTc-HMPAO.
Welling M; Feitsma HI; Blok D; Calame W; Ensing GJ; Goedemans W; Pauwels EK
Q J Nucl Med; 1995 Jun; 39(2):89-98. PubMed ID: 8574810
[TBL] [Abstract][Full Text] [Related]
14. Effect of granulocyte concentration on leukocyte labelling efficiency with 99mTc-HMPAO.
Ballinger JR; Proulx A; Gerson B; Gulenchyn KY
Int J Rad Appl Instrum B; 1990; 17(4):443. PubMed ID: 2387752
[No Abstract] [Full Text] [Related]
15. [Stabilization of 99m Tc-HMPAO with methylene blue: its use in leukocyte labelling)].
García Seguí V; Roca Engroñat M; Armero Muñoz F; Iglesias Allende F; Gomes Barreto de Mélo V; Martin-Comín J
Rev Esp Med Nucl; 1998; 17(4):261-4. PubMed ID: 9721341
[TBL] [Abstract][Full Text] [Related]
16. Simple procedure for red blood cell labeling with Tc-99m HMPAO. Preliminary clinical results.
Vorne M; Laitinen R
Clin Nucl Med; 1992 Jan; 17(1):14-7. PubMed ID: 1311998
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of 99Tcm-HMPAO and 99Tcm-ECD as a leukocyte labelling agent.
Kao CH; Huang WT; Wang YL; Lin KS; Lo JM; Wang SJ
Nucl Med Commun; 1994 Apr; 15(4):294-7. PubMed ID: 8072744
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of 99m Tc-HMPAO-labeled leukocytes and 99m Tc-nanocolloid in osteomyelitis].
Hotze A; Bockisch A; Rüther M; Biersack HJ
Nuklearmedizin; 1988 Mar; 27(2):63-5. PubMed ID: 3368340
[TBL] [Abstract][Full Text] [Related]
19. The development of a clinical protocol for the radiolabelling of mixed leucocytes with 99Tcm-hexamethylpropyleneamine oxime.
Danpure HJ; Osman S; Carroll MJ
Nucl Med Commun; 1988 Jun; 9(6):465-75. PubMed ID: 3412734
[TBL] [Abstract][Full Text] [Related]
20. A rapid method for the preparation of 99Tcm hexametazime-labelled leucocytes.
Solanki KK; Mather SJ; Janabi MA; Britton KE
Nucl Med Commun; 1988 Oct; 9(10):753-61. PubMed ID: 3211434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
